Weekly Newsletter
Excepteur sint occaecat cupidatat non proident
AIDS
HealthNews
U.S. approves GSK’s ViiV Healthcare’s new HIV treatment
United States (U.S.) HIV specialist pharmaceutical company, ViiV Healthcare on Wednesday said that the U.S. Food and Drug Administration (FDA) has approved Cabenuva...
Don't Miss
Why Nigeria’s Banks Still on Shaky Ground with Big Profits, Weak Capital
By Blaise UdunzeDespite the fragile 2024 economy grappling with inflation, currency volatility, and weak growth, Nigeria’s banking industry was widely portrayed as successful...
Why 2026 could be your year of extraordinary breakthroughs
By Chioma ObinagwamYear 2026 will mark the end of ordinary living for those willing to embrace divine discipline and fervent pursuit of God.Confiance...